Kenna Anderes Selected Research

Kenna Anderes Research Topics

Disease

19	Neoplasms (Cancer) 01/2016 - 01/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 09/2012
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2016
2	Breast Neoplasms (Breast Cancer) 01/2016 - 11/2007
2	Circulating Neoplastic Cells 01/2016 - 07/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 04/2012
2	Hypoxia (Hypoxemia) 04/2012 - 12/2010
1	Colorectal Neoplasms (Colorectal Cancer) 04/2024
1	Adenocarcinoma 01/2016
1	Hemorrhage 07/2014
1	Hypertension (High Blood Pressure) 07/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2012
1	Hematologic Neoplasms (Hematological Malignancy) 07/2012
1	Leukemia 07/2012
1	Lymphoma (Lymphomas) 07/2012
1	Inflammation (Inflammations) 11/2011
1	Neoplasm Metastasis (Metastasis) 11/2011
1	Inflammatory Breast Neoplasms 11/2011
1	Rheumatoid Arthritis 11/2011
1	Prostatic Neoplasms (Prostate Cancer) 10/2011
1	Pain (Aches) 03/2011
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2009
1	Carcinoid Tumor (Carcinoid) 10/2009
1	Carcinogenesis 10/2009
1	Ataxia Telangiectasia (Louis Bar Syndrome) 07/2009
1	Skin Neoplasms (Skin Cancer) 07/2009
1	Disease Progression 01/2009
1	Hyperglycemia 12/2002

Drug/Important Bio-Agent (IBA)

6	silmitasertibIBA 09/2012 - 12/2010
5	Casein Kinase II (Casein Kinase 2)IBA 09/2012 - 01/2011
4	Carboxylic AcidsIBA 07/2012 - 01/2011
3	adagrasibIBA 04/2024 - 01/2022
3	Ribosomal DNA (rDNA)IBA 07/2012 - 10/2009
3	RNA Polymerase I (Polymerase I, RNA)IBA 07/2012 - 02/2011
3	CX 5461IBA 07/2012 - 02/2011
2	Bevacizumab (Avastin)FDA Link 07/2014 - 01/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 01/2008
2	ErbB Receptors (EGF Receptor)IBA 09/2012 - 04/2012
2	Gemcitabine FDA Link 04/2012 - 11/2007
2	Interleukin-6 (Interleukin 6)IBA 04/2012 - 11/2011
2	Phosphotransferases (Kinase)IBA 10/2011 - 10/2009
2	Proteins (Proteins, Gene)FDA Link 10/2011 - 10/2009
2	Docetaxel (Taxotere)FDA Link 07/2009 - 01/2009
1	Cetuximab (Erbitux)FDA Link 04/2024
1	B7-H1 AntigenIBA 01/2022
1	PlatinumIBA 01/2022
1	Folate Receptor 1IBA 01/2016
1	AntibodiesIBA 01/2016
1	cediranib (AZD2171)IBA 07/2014
1	NitratesIBA 07/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 07/2014
1	OxidesIBA 07/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2012
1	Tyrosine Kinase InhibitorsIBA 09/2012
1	benzo(c)fluoreneIBA 07/2012
1	RNA (Ribonucleic Acid)IBA 07/2012
1	EnzymesIBA 07/2012
1	Drug CombinationsIBA 04/2012
1	Cisplatin (Platino)FDA LinkGeneric 04/2012
1	proto-oncogene proteins pimIBA 02/2012
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2011
1	CytokinesIBA 11/2011
1	Formaldehyde (Formol)FDA Link 03/2011
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 02/2011
1	Ribosomal RNAIBA 02/2011
1	Adenosine Triphosphate (ATP)IBA 01/2011
1	Monoclonal AntibodiesIBA 11/2010
1	Cadherins (E-Cadherin)IBA 11/2010
1	PF-03732010 monoclonal antibodyIBA 11/2010
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 11/2010
1	CX 3543IBA 10/2009
1	NucleolinIBA 10/2009
1	PF 00477736IBA 07/2009
1	Caffeine (No Doz)FDA LinkGeneric 07/2009
1	Cyclic AMP (AMP, Cyclic)IBA 07/2009
1	Small Interfering RNA (siRNA)IBA 07/2009
1	Capsules (Microcapsules)IBA 01/2009
1	Antineoplastic Agents (Antineoplastics)IBA 01/2009
1	palbociclibIBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 08/2008
1	Glucagon (Glukagon)FDA Link 12/2002

Therapy/Procedure

8	Therapeutics 01/2022 - 08/2008
1	Drug Therapy (Chemotherapy) 01/2022
1	Lasers (Laser) 01/2016